ENDV Stock Performance, Insider Transaction and News

ENDV - ENDONOVO THERAPEUTICS INC

Market Cap	2.82M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-4.4M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-28.00%
Sales	255.72k	PEG	-	EPS past 5Y	-	200D Avg Chg	-28.00%
Dividend	N/A	Price/Book	N/A	EPS next 5Y	-	52W High Chg	-64.00%
Recommedations	-	Quick Ratio	-	Shares Outstanding	349.39M	52W Low Chg	900.00%
Insider Own	22.53%	ROA	-144.27%	Shares Float	246.92M	Beta	-0.36
Inst Own	-	ROE	-	Shares Shorted/Prior	-/-	Price	0.01
Gross Margin	96.21%	Profit Margin	-	Avg. Volume	114,883	Target Price	-
Oper. Margin	-31,105.07%	Earnings Date	-	Volume	61,040	Change	-1.96%

Healthcare | Biotechnology | United States

About ENDONOVO THERAPEUTICS INC

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

ENDONOVO THERAPEUTICS INC News

03/28/24	Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
03/04/24	Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
12/04/23	Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
10/12/23	Endonovo's SofPulse® Secures Taiwan FDA Approval
08/22/23	Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
08/08/23	Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
06/22/23	New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.
06/07/23	Endonovo Pending Agreement to Develop Telehealth Division

ENDV Chatroom

stokpiks Posted - 04/09/24

"The key takeaway here is that SofPulse, Inc. is taking over SofPulse® and being spun out into a new public entity intended to list on NASDAQ via IPO. " Read more: https://smpl.is/8yhx4 $ENDV $MDT $NVRO $NGENF

Howitzerr Posted - 04/03/24

$ENDV 👎🏼

dhollan Posted - 03/27/24

$ENDV Volume is up today

Craig305 Posted - 03/27/24

$ENDV State of ENDV today.

Howitzerr Posted - 03/15/24

$ENDV 👎🏼

Howitzerr Posted - 03/14/24

$ENDV 👎🏼

Howitzerr Posted - 03/13/24

$ENDV 👎🏼

Howitzerr Posted - 03/13/24

$ENDV 👎🏼

Howitzerr Posted - 03/12/24

$ENDV 👎🏼

Howitzerr Posted - 03/11/24

$ENDV 👎🏼

Howitzerr Posted - 03/10/24

$ENDV 👎🏼

Howitzerr Posted - 03/08/24

$ENDV 👎🏼

Howitzerr Posted - 03/07/24

$ENDV 👎🏼

Howitzerr Posted - 03/06/24

$ENDV 👎🏼 @pumperdestroyerVA 😘

Howitzerr Posted - 03/05/24

$ENDV 👎🏼

Howitzerr Posted - 03/04/24

$ENDV 👎🏼

Howitzerr Posted - 03/03/24

$ENDV 👎🏼

Howitzerr Posted - 1 month ago

$ENDV 👎🏼

pumperdestroyerVA Posted - 02/28/24

$ENDV Someone on this board needs to get a life

Howitzerr Posted - 02/28/24

$ENDV 👎🏼

Howitzerr Posted - 02/26/24

$ENDV 👎🏼

Howitzerr Posted - 02/22/24

$ENDV Almost forgot 👎🏼

Howitzerr Posted - 02/20/24

$ENDV @pumperdestroyerVA 👎🏼

Howitzerr Posted - 02/20/24

$ENDV 👎🏼 @pumperdestroyerVA move on 👎🏼

Howitzerr Posted - 02/19/24

$ENDV @pumperdestroyerVA 👎🏼

Howitzerr Posted - 02/18/24

$ENDV @pumperdestroyerVA 👎🏼

Howitzerr Posted - 02/17/24

$ENDV @pumperdestroyerVA 👎🏼

Howitzerr Posted - 02/16/24

$ENDV @pumperdestroyerVA 👎🏼

Howitzerr Posted - 02/15/24

$ENDV 👎🏼

Howitzerr Posted - 02/14/24

$ENDV 👎🏼